Cargando…
Secondary Hyperparathyroidism and Hypertension: An Intriguing Couple
Secondary hyperparathyroidism (SHPTH) is a major complication in patients on maintenance hemodialysis burdened with high cardiovascular risk. Hypertension is also a high prevalence complication contributing to an increase in the mortality rate in hemodialysis patients. A possible association between...
Autores principales: | Simeoni, Mariadelina, Perna, Alessandra F., Fuiano, Giorgio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141131/ https://www.ncbi.nlm.nih.gov/pubmed/32120854 http://dx.doi.org/10.3390/jcm9030629 |
Ejemplares similares
-
Current evidence on the use of anti-RAAS agents in congenital or acquired solitary kidney
por: Simeoni, Mariadelina, et al.
Publicado: (2017) -
Cystatin C, a Controversial Biomarker in Hypothyroid Patients under Levothyroxine Therapy: THYRenal, a Pilot Cohort Observational Study
por: Greco, Marta, et al.
Publicado: (2020) -
Zebrafish as a Model of Cardiac Pathology and Toxicity: Spotlight on Uremic Toxins
por: Coppola, Annapaola, et al.
Publicado: (2023) -
COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis
por: Perna, Alessandra F., et al.
Publicado: (2020) -
Therapeutic Plasmapheresis: A Revision of Literature
por: Altobelli, Claudia, et al.
Publicado: (2022)